Previous Direct Debits

All previous Direct Debits set up with Succinct or Open Health on behalf of BOPA are no longer valid. BOPA no longer use Open Health/Succinct as their Secretariat and all membership is now managed via the new website.

All members should get an email 28 days, 7 days and 2 days before their membership expires. You can then pay online with any card for instant renewal using the link in the email.

Group members and corporate members have been emailed separately- please note that the bank to pay into HAS CHANGED.

For individual members who joined in March  2019: The link sent to your email (at 28 days) will allow you to join for another year. If you wish to join as a recurring member (automatically takes the membership fee out each year) then you will need to log into the website within the 28 day window and then click this link. https://www.bopa.org.uk/join/annual-membership/. You will only need to do this for 2020.

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article